UK company develops nonbiological antibody replication

A belated story from The Register: "The [British] government has handed £1m in grants and awards to a nanotech company that has developed a new way of detecting a bioterror attack. The Department of Trade and Industry (DTI) and the National Endowment for Science, Technology and the Arts (Nesta) both contributed to the funding package. The company concerned, Nanosight, is cagey about explaining its technology because its patents are all still under review. What it will say is that it has developed a way of replicating viral antibodies using non-biological means, specifically 'computer and microelectronics technology'." The submittor of this item commented: "The story centers around a bio-weapon detector, however, I feel the promise of non-biological production of viral/bacterial antibodies is much more interesting."